RxDoctor Payments Data

Angel Reyes Diaz, MD

Family Medicine · Northfield, NJNPI 1942837596

Payments from drug & device makers

$2,631in general payments, 2019–2025

Across 142 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$529
  • Bayer$226
  • Astellas Pharma US Inc$220
  • Lilly USA, LLC$193
  • Phathom Pharmaceuticals, Inc.$177
  • AbbVie$174
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,54997%
  • Education$823%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,631 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$45,560
Medicare patients
203
Services billed
409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin29$21,545
EliquisApixaban20$8,406
Atorvastatin Calcium88$1,178
Rosuvastatin Calcium37$562
Albuterol Sulfate HfaAlbuterol Sulfate14$359
Amlodipine Besylate77$355
Quetiapine Fumarate17$351
Losartan Potassium35$322
Metformin Hcl53$319
Tamsulosin Hcl20$284
Levothyroxine Sodium28$270
Montelukast Sodium12$270
Diclofenac Sodium14$266
Gabapentin32$255
Alprazolam38$255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$65$21,54529 claims
PfizerEliquis$119$8,40620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Northfield

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →